Effect of the novel dual orexin receptor antagonist daridorexant on night‐time respiratory function and sleep in patients with moderate chronic obstructive pulmonary disease-Reference-Cited by-同舟云学术

Effect of the novel dual orexin receptor antagonist daridorexant on night‐time respiratory function and sleep in patients with moderate chronic obstructive pulmonary disease

Published:2021-01-08 Issue:4 Volume:30 Page:
ISSN:0962-1105
Container-title:Journal of Sleep Research
language:en
Short-container-title:J Sleep Res

Author:

Boof Marie‐Laure¹^ORCID,Dingemanse Jasper¹^ORCID,Brunke Mareile²,Esselmann Albert³,Heymer Peter⁴,Kestermann Olaf⁵,Lederer Katharina⁶^ORCID,Fietze Ingo⁶^ORCID,Ufer Mike¹^ORCID

Affiliation:

1. Department of Clinical Pharmacology Idorsia Pharmaceuticals Ltd Allschwil Switzerland

2. Klinische Forschung Hannover‐Mitte GmbH Hannover Germany

3. Zentrum für Medizinische Studien GmbH Warendorf Germany

4. Klinische Forschung Dresden GmbH Dresden Germany

5. framol‐med GmbH Lungenpraxis Rheine Rheine Germany

6. Advanced Sleep Research Berlin Germany

Publisher

Wiley

Subject

Behavioral Neuroscience,Cognitive Neuroscience,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jsr.13248

Reference40 articles.

1. Respiratory medications and sleep

2. Effect of the new dual orexin receptor antagonist daridorexant on nighttime respiratory function and sleep in patients with mild and moderate obstructive sleep apnea;Boof M. L.;Sleep,2020

3. Promotion of sleep by targeting the orexin system in rats, dogs and humans

4. Insomnia in Patients with COPD

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Respiratory safety of lemborexant in adult and elderly subjects with moderate‐to‐severe chronic obstructive pulmonary disease;Journal of Sleep Research;2024-09-12

2. Effect of Daridorexant on the Pharmacokinetics of P-Glycoprotein Substrate Dabigatran Etexilate and Breast Cancer Resistance Protein Substrate Rosuvastatin in Healthy Subjects;Clinical Drug Investigation;2023-10-19

3. Daridorexant, an Orexin Receptor Antagonist for the Management of Insomnia;American Journal of Therapeutics;2023-07

4. Daridorexant, a Recently Approved Dual Orexin Receptor Antagonists (DORA) in Treatment of Insomnia;Sleep Science;2023-06

5. Daridorexant in Insomnia Disorder: A Profile of Its Use;CNS Drugs;2023-02-08